UNSPSC 51141559: Loreclezole

This classification denotes an anticonvulsant agent with the molecular formula C10H6Cl3N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6DJ32STZ5W, chemically known as 1h-1,2,4-triazole, 1-(2-chloro-2-(2,4-dichlorophenyl)ethenyl)-, (z)- but generally known as loreclezole, which bears US NIH Compound Identifier 3034012. European Medicines Agency schedules Loreclezole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08586MIG.

UNSPSC 51141559 Loreclezole is a Commodity code that nominally covers a specific pharmaceutical compound, yet recent state and local solicitations under this code show a mismatch between the code's abstract designation and actual procurement activity. The single recorded recent opportunity—Seminole County, Florida's IFB 60459723LAS—solicits Naloxone and Safe Drug Deactivation Systems, products unrelated to Loreclezole. This divergence signals either a data-entry error in the coding assignment or that the code is being used opportunistically to capture emergency-response pharmaceuticals and harm-reduction equipment outside its formal scope. State and local health departments, counties, and community health agencies appear to be the primary issuing bodies under this code when activity does occur, though the opportunity block contains no evidence of repeat buyers or sustained procurement volume across multiple jurisdictions.

Seminole County, Florida represents the only recent activity visible in this code's record. The county issued the IFB on June 30, 2026, with a response deadline of July 26, 2023—a date discrepancy in the source that suggests either a historical posting or a data-capture error. The procurement calls for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems delivered quarterly to the Seminole County Community Health Building in Sanford. The contract structure includes a two-year initial term with a one-year renewal option, fixed-fee pricing, and potential FEMA funding. Bidders must comply with federal regulations including the Clean Air Act, provide E-Verify certification, and carry workers' compensation and commercial general liability insurance. No set-aside designations are specified. The code shows limited recent activity; business development professionals should verify whether the code is actively used by other state and local health agencies or whether this represents an isolated procurement anomaly.